X4 Pharmaceuticals logo

X4 Pharmaceuticals share price today

(XFOR)

X4 Pharmaceuticals share price is $0.74 & ₹63.50 as on 7 Jan 2025, 2.30 'hrs' IST

$0.74

Market is closed - opens 8 PM, 07 Jan 2025

View live X4 Pharmaceuticals share price in Dollar and Rupees. Guide to invest in X4 Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in X4 Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

X4 Pharmaceuticals share price movements

  • Today's Low: $0.68
    Today's High: $0.77

    Day's Volatility :11.61%

  • 52 Weeks Low: $0.26
    52 Weeks High: $1.60

    52 Weeks Volatility :83.68%

X4 Pharmaceuticals Returns

PeriodX4 Pharmaceuticals IncIndex (Russel 2000)
3 Months
37.17%
0.0%
6 Months
24.93%
0.0%
1 Year
-13.88%
0.0%
3 Years
-65.0%
-19.8%

X4 Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$0.7421
Open
$0.7421
Today's High
$0.77
Today's Low
$0.6806
Market Capitalization
$125.1M
Today's Volume
$2.1M
52 Week High
$1.6
52 Week Low
$0.2612
Revenue TTM
$563.0K
EBITDA
$-123.2M
Earnings Per Share (EPS)
$-0.08
Profit Margin
3131.79%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
21.77%

How to invest in X4 Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in X4 Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the X4 Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for X4 Pharmaceuticals or XFOR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of X4 Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of X4 Pharmaceuticals shares which would translate to 1.160 fractional shares of X4 Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like X4 Pharmaceuticals, in just a few clicks!

Returns in X4 Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

X4 Pharmaceuticals investment value today

Current value as on today

₹89,269

Returns

₹10,731

(-10.73%)

Returns from X4 Pharmaceuticals Stock

₹13,953 (-13.95%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards X4 Pharmaceuticals

140.91%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Investment in X4 Pharmaceuticals from India has grown in the last 30 days as on Jan 7, 2025. 140.91% more purchase transactions for X4 Pharmaceuticals in the last 30 days versus the previous period.

56%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for X4 Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 56% more investors are searching X4 Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in X4 Pharmaceuticals

  • Bain Capital Life Sciences Investors, LLC

    9.92%

  • NEA Management Company, LLC

    8.79%

  • BlackRock Inc

    6.26%

  • Vanguard Group Inc

    4.95%

  • Orbimed Advisors, LLC

    4.18%

  • Kingdon Capital Management LLC

    2.72%

Analyst Recommendation on X4 Pharmaceuticals

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for X4 Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on X4 Pharmaceuticals

What analysts predicted

Upside of 311.93%

Current:

$0.74

Target:

$3.05

Insights on X4 Pharmaceuticals

  • Price Movement

    In the last 7 days, XFOR stock has moved down by -8.2%
  • XFOR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 29.8%
  • XFOR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 121.8%
  • Price to Sales

    ForXFOR every $1 of sales, investors are willing to pay $247.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

X4 Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

X4 Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

X4 Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
X4 Pharmaceuticals Inc
40.58%
24.93%
-13.88%
-65.0%
-92.82%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
X4 Pharmaceuticals Inc
2.85
NA
NA
-0.15
0.22
-0.4
NA
0.31
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
X4 Pharmaceuticals Inc
Buy
$125.1M
-92.82%
2.85
3131.79%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About X4 Pharmaceuticals

x4 pharmaceuticals is developing novel therapeutics designed to improve immune cell trafficking and reverse immune suppression, which is fundamental to treating cancer and certain rare, genetic primary immunodeficiency diseases. our oral, small molecule drug candidates inhibit the binding of chemokine cxcl12 to c-x-c receptor type 4 (cxcr4), a receptor-ligand pair that plays an essential role in normal immune surveillance. we are committed to advancing the fields of cancer immunotherapy and genetic immune disorders through innovation and investment in our proprietary clinical and preclinical pipeline. x4’s most advanced product candidate, x4p-001-rd, is in a phase 2/3 study in patients with whim syndrome, a rare genetic, primary immunodeficiency disease. x4p-001-io is currently under investigation in multiple phase 1/2 studies in refractory clear cell renal cell carcinoma (ccrcc) and melanoma. our third program, x4p-002, is in preclinical development and designed specifically for the t
Organization
X4 Pharmaceuticals
Employees
127
CEO
Dr. Paula Ragan Ph.D.
Industry
Biotechnology

Management People of X4 Pharmaceuticals

NameTitle
Dr. Paula Ragan Ph.D.
CEO, President & Director
Mr. Adam S. Mostafa
CFO, Treasurer & Corporate Secretary
Dr. Christophe Arbet-Engels M.B.A., M.D., Ph.D.
Chief Medical Officer
Dr. Richard Peters M.D., Ph.D.
Founder
Dr. Renato T. Skerlj Ph.D.
Founder
Dr. Keith T. Flaherty M.D.
Founder & Member of Corporate Advisory Board
Dr. Mary DiBiase Ph.D.
Chief Operating Officer
Dr. Arthur Taveras Ph.D.
Chief Scientific Officer
Dr. Robert David Arbeit
Senior Vice President of Clinical Development and Translational Research
Mr. Mark Baldry M.B.A.
Chief Commercial Officer

Important FAQs about investing in X4 Pharmaceuticals from India :

What is X4 Pharmaceuticals share price today?

X4 Pharmaceuticals share price today stands at $0.74, Open: $0.74 ; Previous Close: $0.74 ; High: $0.77 ; Low: $0.68 ; 52 Week High: $1.60 ; 52 Week Low: $0.26. The stock opens at $0.74, after a previous close of $0.74. The stock reached a daily high of $0.77 and a low of $0.68, with a 52-week high of $1.60 and a 52-week low of $0.26.

Can Indians buy X4 Pharmaceuticals shares?

Yes, Indians can invest in the X4 Pharmaceuticals (XFOR) from India.

With INDmoney, you can buy X4 Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy X4 Pharmaceuticals at zero transaction cost.

How can I buy X4 Pharmaceuticals shares from India?

It is very easy to buy X4 Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of X4 Pharmaceuticals be purchased?

Yes, you can buy fractional shares of X4 Pharmaceuticals with INDmoney app.

What are the documents required to start investing in X4 Pharmaceuticals stocks?

To start investing in X4 Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of X4 Pharmaceuticals

Today’s highest price of X4 Pharmaceuticals (XFOR) is $0.77.

Today’s lowest price of X4 Pharmaceuticals (XFOR) is $0.68.

What is today's market capitalisation of X4 Pharmaceuticals

Today's market capitalisation of X4 Pharmaceuticals XFOR is 125.1M

What is the 52 Week High and Low Range of X4 Pharmaceuticals

  • 52 Week High

    $1.60

  • 52 Week Low

    $0.26

What are the historical returns of X4 Pharmaceuticals?

  • 1 Month Returns

    40.58%

  • 3 Months Returns

    24.93%

  • 1 Year Returns

    -13.88%

  • 5 Years Returns

    -92.82%

Who is the Chief Executive Officer (CEO) of X4 Pharmaceuticals

Dr. Paula Ragan Ph.D. is the current Chief Executive Officer (CEO) of X4 Pharmaceuticals.